{
    "organizations": [],
    "uuid": "1730d35663fa77704535dbf5da65aae6c898a275",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-senzagen-signs-global-licensing-ag/brief-senzagen-signs-global-licensing-agreement-with-eurofins-bpt-munich-idUSFWN1Q50P5",
    "ord_in_thread": 0,
    "title": "BRIEF-SenzaGen Signs Global Licensing Agreement With Eurofins BPT Munich",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 15 (Reuters) - SENZAGEN AB:\n* SENZAGEN SIGNS ITS FIRST GLOBAL LICENSING AGREEMENT WITH EUROFINS BIOPHARMA PRODUCT TESTING MUNICH\n* EUROFINS WILL INCLUDE GARDSKIN AND ADD ON TEST GARDPOTENCY AS A DIAGNOSTIC TOOL IN CHEMICAL SAFETY TESTING SERVICESâ€‹ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-15T17:33:00.000+02:00",
    "crawled": "2018-02-16T17:01:14.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "senzagen",
        "ab",
        "senzagen",
        "sign",
        "first",
        "global",
        "licensing",
        "agreement",
        "eurofins",
        "biopharma",
        "product",
        "testing",
        "munich",
        "eurofins",
        "include",
        "gardskin",
        "add",
        "test",
        "gardpotency",
        "diagnostic",
        "tool",
        "chemical",
        "safety",
        "testing",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}